IQVIA at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

IQVIA takes part in 2 sessions at ACT 2026 in San Antonio. Its program centres on new approach methods, applied to predicting immune responses against drug candidates and to screening for nerve damage and repair in safety testing of central nervous system drugs.

OrganizationACT 2026 Attendance
IQVIA
Durham, NC
iqvia.com
Contract research organizations (CROs)
Clinical research and health data company; its laboratories unit runs bioanalytical, immunogenicity and in vitro safety assays.
Poster
Mon Nov 16
5:00pm–6:30pm
New Approach Methodologies for Immunogenicity Risk Assessment and Functional Evaluation of Drug Candidates (P303)
Nelson Exhibit Ballroom · Poster P303
New approach methods · Immunotoxicology
Poster
Mon Nov 16
5:00pm–6:30pm
Phenotypic Screening Platforms for Neurotoxicity and Neurorepair in CNS Drug Safety Assessment (P431)
Nelson Exhibit Ballroom · Poster P431
Neurotoxicology · New approach methods

Explore the full ACT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full ACT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from IQVIA

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction